SyncAV Post-Market Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1686 participants.

Also called NCT04100148

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,686 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04100148
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Austria, Belgium, Canada, China, Finland, France, Germany, Hong Kong SAR China, India, Italy, Japan, Netherlands, Poland, Portugal, Puerto Rico, Russia, Saudi Arabia, Serbia, South Korea, Spain, Sweden, Taiwan, Thailand, United Kingdom (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04100148. Randomized; no masking; primary purpose treatment. Start 2019-10-03 (actual); primary completion 2026-05-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
SyncAV Post-Market Trial
Acronym
SyncAV
Condition
Congestive Heart Failure
Intervention (Device)
SyncAV programmed ON
Intervention (Device)
Fixed AV delay
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct04100148
Content hash
dff3e8535ffb7a3a5feda59a538d8c98d1624ac4b43b97995a3c2426f3135a13